Only 15% of patients with anaphylaxis receive epinephrine from paramedics

American College of Allergy, Asthma, and ImmunologyNov 9 2012

Epinephrine is the first line of treatment for patients suffering from anaphylaxis, a life-threatening allergic reaction. A delay in using epinephrine is common in severe food allergic reaction deaths. Yet according to a new study presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting in Anaheim, Calif. Nov. 8-13, only 15 percent of those experiencing anaphylaxis receive epinephrine from paramedics.

Authors conclude that "paramedic education on the indications and use of epinephrine for allergic reactions and anaphylaxis needs to be implemented."